PRNB insider filings

Principia Biopharma Inc. — 17 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2020-09-28. Screen PRNB transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for PRNB between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Principia Biopharma Inc.

FiledFormInsiderReported transactionsSource
2020-09-284Tomasello Shawn — DirectorDisposition to issuer (D): 20,475 (derivative) · Disposition to issuer (D): 10,240 (derivative)EDGAR
2020-09-284George Simeon — DirectorCode (U): 2,982,855 @ $100 · Disposition to issuer (D): 28,623 (derivative) · Disposition to issuer (D): 20,475 (derivative) · Disposition to issuer (D): 10,240 (derivative) · Disposition to issuer (D): 10,240 (derivative)EDGAR
2020-09-284Lin Shao-Lee — DirectorDisposition to issuer (D): 20,475 (derivative) · Disposition to issuer (D): 10,240 (derivative) · Disposition to issuer (D): 10,240 (derivative)EDGAR
2020-09-284Becker Daniel J. — DirectorCode (U): 667,600 @ $100 · Disposition to issuer (D): 20,475 (derivative) · Disposition to issuer (D): 10,240 (derivative) · Disposition to issuer (D): 10,240 (derivative)EDGAR
2020-09-284Wolff Stefani — Chief Development OfficerGift (G): 5,504 @ $0 · Code (U): 13,592 @ $100 · Disposition to issuer (D): 30,056 (derivative) · Disposition to issuer (D): 16,843 (derivative) · Disposition to issuer (D): 22,017 (derivative) · Disposition to issuer (D): 55,042 (derivative) · +2 moreEDGAR
2020-09-284Thomas Dolca — Chief Medical OfficerCode (U): 2,207 @ $100 · Disposition to issuer (D): 168,057 (derivative) · Disposition to issuer (D): 60,000 (derivative) · Disposition to issuer (D): 55,000 (derivative)EDGAR
2020-09-284Goldstein David M — Chief Scientific OfficerCode (U): 31,826 @ $100 · Disposition to issuer (D): 12,960 (derivative) · Disposition to issuer (D): 13,210 (derivative) · Disposition to issuer (D): 8,807 (derivative) · Disposition to issuer (D): 15,412 (derivative) · Disposition to issuer (D): 22,017 (derivative) · +4 moreEDGAR
2020-09-284Hardiman Roy C. — Chief Business OfficerCode (U): 117,761 @ $100 · Code (U): 1,916 @ $100 · Disposition to issuer (D): 11,519 (derivative) · Disposition to issuer (D): 44,034 (derivative) · Disposition to issuer (D): 60,000 (derivative) · Disposition to issuer (D): 55,000 (derivative)EDGAR
2020-09-284Babler Martin — President, CEO, DirectorCode (U): 1,023 @ $100 · Code (U): 39,179 @ $100 · Code (U): 18,355 @ $100 · Disposition to issuer (D): 255 (derivative) · Disposition to issuer (D): 50,795 (derivative) · Disposition to issuer (D): 85,728 (derivative) · +7 moreEDGAR
2020-09-284CHAI CHRISTOPHER Y — Chief Financial OfficerCode (U): 3,799 @ $100 · Code (U): 3,302 @ $100 · Disposition to issuer (D): 56,982 (derivative) · Disposition to issuer (D): 24,769 (derivative) · Disposition to issuer (D): 29,723 (derivative) · Disposition to issuer (D): 13,210 (derivative) · +4 moreEDGAR
2020-09-284Colowick Alan — DirectorDisposition to issuer (D): 47,724 (derivative) · Disposition to issuer (D): 20,475 (derivative) · Disposition to issuer (D): 10,240 (derivative) · Disposition to issuer (D): 10,240 (derivative)EDGAR
2020-09-284Machado Patrick — DirectorDisposition to issuer (D): 20,475 (derivative) · Disposition to issuer (D): 10,240 (derivative) · Disposition to issuer (D): 10,240 (derivative)EDGAR
2020-09-224Hardiman Roy C. — Chief Business OfficerOption exercise (M): 2,758 @ $4.72 · Option exercise (M): 2,242 @ $7.27 · Sale (S): 5,000 @ $99.98 · Option exercise (M): 2,758 (derivative) @ $0 · Option exercise (M): 2,242 (derivative) @ $0EDGAR
2020-08-204Thomas Dolca — Chief Medical OfficerOption exercise (M): 15,000 @ $23.77 · Sale (S): 15,000 @ $100 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2020-08-204CHAI CHRISTOPHER Y — Chief Financial OfficerOption exercise (M): 7,500 @ $3.00 · Sale (S): 7,500 @ $99.37 · Option exercise (M): 7,500 (derivative) @ $0EDGAR
2020-08-204BVF PARTNERS L P/IL — 10% owner
BIOTECHNOLOGY VALUE FUND L P
BVF I GP LLC
BIOTECHNOLOGY VALUE FUND II LP
BVF II GP LLC
Biotechnology Value Trading Fund OS LP
BVF Partners OS Ltd.
BVF GP HOLDINGS LLC — 10% owner
BVF INC/IL — 10% owner
LAMPERT MARK N — 10% owner
Purchase (P): 1,205 (derivative) @ $35.79 · Purchase (P): 905 (derivative) @ $35.79 · Purchase (P): 158 (derivative) @ $35.79EDGAR
2020-08-124Goldstein David M — Chief Scientific OfficerOption exercise (M): 2,447 @ $3.00 · Option exercise (M): 3,553 @ $3.18 · Sale (S): 858 @ $86.11 · Sale (S): 700 @ $86.92 · Sale (S): 2,534 @ $88.40 · Sale (S): 700 @ $89.68 · +4 moreEDGAR

Recent 8-K events — Principia Biopharma Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2020-09-288-K2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2020-08-178-K1.01 — Entry into a Material Definitive Agreement
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2020-08-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=PRNB returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs